Alnylam Pharmaceuticals is a pioneer in designing therapeutics based on RNA interference, or RNAi, a mechanism that occurs naturally in cells and silences overexpressed genes, which often cause ...

Codexis, Inc. (NASDAQ:CDXS) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. On March 12, Matt Hewitt of Craig-Hallum reiterated his Buy rating on Codexis, Inc. (NASDAQ:CDXS).

Ellipsis Health partners with PromptWell to boost enrollment in patient care programs, while CaryHealth teams up with HealthDyne to enhance medication management.

Efforts Aimed at Facilitating Earlier Diagnosis, Coordinated Care, and Long-Term Patient Impact in ATTR-CM – − Alnylam to ...

Sarepta Therapeutics is navigating a transition from a profitable rare-disease company to a capital-intensive, multi-platform ...

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, ...

Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.

Biopesticides represent a kind of Utopian destination in the landscape of agricultural sustainability. If only they could ...

Balancing nitrogen use is critical for maximizing crop yield while minimizing environmental and economic costs. A new approach integrates drone-based multispectral imaging with machine learning to ...

Abstract: Recently, high-content screening (HCS) has been combined with RNA interference (RNAi) to become an essential image-based high-throughput method for studying genes and biological networks ...

Thinking about your next corn planting season? Bayer corn seed has been doing some interesting things lately, with new tech to help keep your crops healthy and productive. From fighting off those ...

"2025 proved that our technology delivers, not in the distant future, but right now," says Tropic CEO Gilad Gershon.